Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Jun 24:3:25.
doi: 10.21037/sci.2016.06.06. eCollection 2016.

A rare case of the upper extremity diffuse large B-cell lymphoma mimicking soft tissue sarcoma in an elderly patient

Aleksandra Mamorska-Dyga  1 , Faisal M H Ronny  1 , Carmelo Puccio  1 , Humayun Islam  1 , Delong Liu  1
Affiliations
Case Reports

A rare case of the upper extremity diffuse large B-cell lymphoma mimicking soft tissue sarcoma in an elderly patient

Aleksandra Mamorska-Dyga et al. Stem Cell Investig. .

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, with about 30% of new cases presenting with extranodal disease. Lesions originating from soft tissues of the upper extremities are extremely rare and may mimic other malignancies like sarcoma. We present a case of an elderly patient with right upper extremity (RUE) mass which was proven to be DLBCL instead of sarcoma. We emphasize the increasing need for investigating new therapeutic options for patients of extreme age and/or with underlying heart disease.

Keywords: Diffuse large B-cell lymphoma (DLBCL); right upper extremity (RUE); targeted agents.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Immunohistochemical studies of the specimen from core biopsies of the right upper extremity mass. The specimens were positive for CD20, Pax5, BCL2, and Ki67. The magnifications are 20× for the figures.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol 2014;89:310-4. 10.1002/ajh.23638 - DOI - PubMed
    1. Derenzini E, Casadei B, Pellegrini C, et al. Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series. Clin Lymphoma Myeloma Leuk. 2013;13:258-65. 10.1016/j.clml.2012.10.003 - DOI - PubMed
    1. Gutiérrez-García G, Colomo L, Villamor N, et al. Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 2010;51:1225-32. 10.3109/10428194.2010.483301 - DOI - PubMed
    1. Coiffier B, Thieblemont C, Van Den Neste E, et al. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood 2010;116:2040-5. 10.1182/blood-2010-03-276246 - DOI - PMC - PubMed
    1. Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005;23:4117-26. 10.1200/JCO.2005.09.131 - DOI - PubMed

Publication types

LinkOut - more resources